EVEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Evex, and what generic alternatives are available?
Evex is a drug marketed by Roche Palo and is included in two NDAs.
The generic ingredient in EVEX is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
Summary for EVEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 3,410 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EVEX at DailyMed |
US Patents and Regulatory Information for EVEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche Palo | EVEX | estrogens, esterified | TABLET;ORAL | 084215-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Roche Palo | EVEX | estrogens, esterified | TABLET;ORAL | 083376-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |